- Home
- PRLD vs CCLD Comparison
PRLD vs CCLD Comparison
Compare PRLD & CCLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- CCLD
- Stock Information
- Founded
- PRLD 2016
- CCLD 1999
- Country
- PRLD United States
- CCLD United States
- Employees
- PRLD N/A
- CCLD N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- CCLD Computer Software: Prepackaged Software
- Sector
- PRLD Health Care
- CCLD Technology
- Exchange
- PRLD Nasdaq
- CCLD Nasdaq
- Market Cap
- PRLD 50.1M
- CCLD 52.5M
- IPO Year
- PRLD 2020
- CCLD 2014
- Fundamental
- Price
- PRLD $0.89
- CCLD $2.02
- Analyst Decision
- PRLD Strong Buy
- CCLD Buy
- Analyst Count
- PRLD 2
- CCLD 2
- Target Price
- PRLD $4.50
- CCLD $3.00
- AVG Volume (30 Days)
- PRLD 137.5K
- CCLD 616.6K
- Earning Date
- PRLD 05-06-2025
- CCLD 05-06-2025
- Dividend Yield
- PRLD N/A
- CCLD N/A
- EPS Growth
- PRLD N/A
- CCLD N/A
- EPS
- PRLD N/A
- CCLD N/A
- Revenue
- PRLD $7,000,000.00
- CCLD $112,507,000.00
- Revenue This Year
- PRLD N/A
- CCLD $2.74
- Revenue Next Year
- PRLD N/A
- CCLD $7.52
- P/E Ratio
- PRLD N/A
- CCLD N/A
- Revenue Growth
- PRLD N/A
- CCLD N/A
- 52 Week Low
- PRLD $0.61
- CCLD $1.14
- 52 Week High
- PRLD $6.80
- CCLD $4.84
- Technical
- Relative Strength Index (RSI)
- PRLD 51.42
- CCLD 54.09
- Support Level
- PRLD $0.77
- CCLD $1.96
- Resistance Level
- PRLD $1.00
- CCLD $2.14
- Average True Range (ATR)
- PRLD 0.11
- CCLD 0.11
- MACD
- PRLD -0.01
- CCLD -0.01
- Stochastic Oscillator
- PRLD 37.18
- CCLD 29.18
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About CCLD CareCloud Inc.
CareCloud Inc is a healthcare information technology company. It provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, telehealth, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue generating segment, and Practice Management.